The healthcare industry in Washington, D.C. is constantly evolving, and Holland & Knight Health Dose provides a comprehensive weekly update on the latest legislative and regulatory developments that impact this sector. This newsletter is designed to keep stakeholders informed and up-to-date on the most important news in the health sector.
In this week’s edition, there are several highlights worth noting. The FDA has been discussing its oversight of clinical decision support software, which is becoming increasingly popular among healthcare providers. There have also been discussions on approaches to digital health tools, which are becoming more prevalent in the industry. Other topics covered include surprise billing, Medicare physician payment reform, and potential changes to PBM, 340B, and Medicare PFS reforms in a Lame Duck Health Package.
In addition to these topics, there have also been retirements in the healthcare sector, as well as a recent analysis of Medicare ACOs (Accountable Care Organizations). A new Center for Clinical Trial Innovation has been established, and updates from the FTC (Federal Trade Commission) and ONC (Office of the National Coordinator for Health Information Technology) are also covered in this issue.
For more information on these topics and more, be sure to read the full Health Dose newsletter.